January 15, 2026
1 min read

BD budgets $110M to expand Neb. syringe production

Becton, Dickinson and Company will shell out $110 million to expand prefillable syringe production at its Columbus, Nebraska, manufacturing plant. The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical reshoring in the U.S., the company said.

Leave a Reply

Your email address will not be published.

Previous Story

Kaiser Permanente, DOJ reach $556 million Medicare Advantage fraud settlement, the largest of its kind

Next Story

Hospitals and doctors are ignoring RFK Jr.’s new vaccine schedule and relying on pediatricians’ guidance instead

Previous Story

Kaiser Permanente, DOJ reach $556 million Medicare Advantage fraud settlement, the largest of its kind

Next Story

Hospitals and doctors are ignoring RFK Jr.’s new vaccine schedule and relying on pediatricians’ guidance instead

Latest from Blog

FDA finally analyzed its own youth tobacco data

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. A lot of people had reactions, comments, and theories regarding Lizzy’s story
Go toTop